lorlatinib
ItalyDrugs containing this active substance
-
It is used to treat adults with an advanced form of ALK-positive non-small cell lung cancer (NSCLC).
Form: tablets, film-coated
Active substance Dosage lorlatinib - ATC: L01ED05
Manufacturer: PFIZER EUROPE MA EEIG